Chen S-J SJ - OmicsDI

Show results for

Unknown (1845)
Genomics (67)
Proteomics (44)
Transcriptomics (13)
Metabolomics (12)

Organisms

Homo sapiens (90)
Mus musculus (4)
Zea mays (3)
Rattus norvegicus (3)
Arabidopsis thaliana (2)
Escherichia coli (2)
Klebsiella pneumoniae (2)
Klebsiella variicola (2)
Staphylococcus aureus (2)
Streptococcus pyogenes (2)
Ciona intestinalis (1)
Vibrio alginolyticus 40B (1)
Chlorocebus sabaeus (1)
Saccharomyces cerevisiae (1)
Streptococcus pyogenes STAB901 (1)

Organisms

Homo sapiens (1)

Repository

EGA (63)
pride (29)
biostudies-arrayexpress (15)
MetaboLights (11)
MassIVE (8)
PAXDB (4)
iProX (2)
geo (1)
GNPS (1)
PanoramaPublic (1)
ENA (1)

Tissue

Cell culture (10)
Epithelial cell (4)
Permanent cell line cell (4)
Kidney (3)
Lung (2)
B cell (1)
Blood plasma (1)
Brain (1)
Dura mater (1)
Islet of Langerhans (1)
Liver (1)
Lymph node (1)
Lymphoid cell (1)
Pancreatic islet (1)
Tear (1)
Type B pancreatic cell (1)

Disease

Prostate adenocarcinoma (2)
Type 2 diabetes mellitus (2)
Breast cancer (1)
COVID-19 (1)
Disease free (1)
Hydrocephalus (1)
Immune system disease (1)
Mixed disorder as reaction to stress (1)
Prostate cancer (1)

Technology Type

Mass Spectrometry (29)
Shotgun proteomics (14)
Mass spectrometry (10)
Bottom-up proteomics (4)
Data-dependent acquisition (4)
SWATH MS (4)
Affinity purification coupled with mass spectrometry proteomics (2)
Top-down proteomics (2)
Affymetrix_U133v2, Illumina HiSeq 2000 (1)
ILLUMINA, Illumina HiSeq 2000 (1)
ILLUMINA, Illumina HiSeq 2500 (1)
Illumina Genome Analyzer II (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Mass spectrometry assay (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Gel-based experiment (1)
Glycoproteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
LTQ Orbitrap Velos (2)
TripleTOF 5600 (2)
Illumina HiSeq 4000 (1)
LTQ FT (1)
MaXis (1)
LTQ Orbitrap Elite (1)
LTQ Velos (1)
Orbitrap Fusion Lumos (1)
Q Exactive Plus (1)
TripleTOF 6600 (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - - reverse phase (1)
Liquid Chromatography MS - alternating – hilic (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS -neg - hilic (1)
Liquid Chromatography MS – pos - hilic (1)
MS Imaging - (1)

Publication Date

2023 (11)
2021 (11)
2020 (8)
2024 (6)
2022 (5)
2017 (4)
2025 (4)
2012 (3)
2010 (3)
2009 (3)
2014 (2)
2005 (2)
2018 (2)
2013 (1)
2006 (1)
2015 (1)
2026 (1)
2019 (1)
2016 (1)

UNIPROT ID/AC

14331_ORYSJ (1)
14331_SOLLC (1)
14334_ORYSJ (1)
14335_SOLLC (1)
14337_ORYSJ (1)
14337_SOLLC (1)
14338_SOLLC (1)
1433B_SOYBN (1)
2A5K_ORYSJ (1)
2ABA_ORYSJ (1)
3055.EDP00778 (1)
3055.EDP02272 (1)
3055.EDP03640 (1)
3055.EDP03813 (1)
3055.EDP04366 (1)
3847.GLYMA06G11530.1 (1)
3847.GLYMA07G36560.3 (1)
3847.GLYMA08G02375.1 (1)
3847.GLYMA08G11940.1 (1)
3847.GLYMA08G19320.1 (1)
3847.GLYMA09G19800.2 (1)
3847.GLYMA11G00590.2 (1)
3847.GLYMA11G15650.4 (1)
3847.GLYMA11G15700.1 (1)
3847.GLYMA11G15820.1 (1)
3847.GLYMA11G15850.4 (1)
3847.GLYMA11G15890.2 (1)
3847.GLYMA11G16040.1 (1)
3847.GLYMA11G16090.1 (1)
3847.GLYMA11G16190.1 (1)

CHEBI ID

CHEBI:16359 (4)
CHEBI:28865 (4)
CHEBI:35038 (3)
CHEBI:116314 (2)
CHEBI:139138 (2)
CHEBI:143745 (2)
CHEBI:143757 (2)
CHEBI:15611 (2)
CHEBI:16196 (2)
CHEBI:16235 (2)
CHEBI:16551 (2)
CHEBI:16704 (2)
CHEBI:16811 (2)
CHEBI:16865 (2)
CHEBI:16870 (2)
CHEBI:16919 (2)
CHEBI:173703 (2)
CHEBI:17750 (2)
CHEBI:182784 (2)
CHEBI:195271 (2)
CHEBI:26078 (2)
CHEBI:27432 (2)
CHEBI:27781 (2)
CHEBI:27997 (2)
CHEBI:28716 (2)
CHEBI:33508 (2)
CHEBI:34494 (2)
CHEBI:34687 (2)
CHEBI:55328 (2)
CHEBI:64489 (2)

Metabolite Name

Cholic acid (3)
Tris(2-butoxyethyl) phosphate (3)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
9(10)-EpOME (2)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
Butyrylcarnitine (2)
Creatine (2)
Dibutyl phthalate (DBP) (2)
Elaidic acid (2)
Guanine (2)
Lyso-PC(16:0) (2)
Monoolein (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Taurocholic acid (2)
Taurocholic acid (2)
(-)-3-Cyanomethyl-3-hydroxy-1H-indol-2(3H)-one (1)
(5-L-Glutamyl)-L-glutamine (1)
(R)-4-((3R,4R,5S,8S,9S,10R,13R,14S,17R)-3,4-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
1,3,5-triprop-2-enyl-1,3,5-triazaperhydroine-2,4,6-trione (1)
1,4a-dimethyl-9-oxo-7-propan-2-yl-3,4,10,10a-tetrahydro-2H-phenanthrene-1-carboxylic acid (1)
1-(9Z-Octadecenoyl)-sn-glycero-3-phosphocholine (1)
1-Arachidonoylglycerophosphoinositol (1)
1-Heptadecanoyl-sn-glycero-3-phosphocholine (1)
1-Hexadecanoyl-sn-glycerol (1)
1-Hexadecyl-sn-glycero-3-phosphocholine (1)
1-Methylhistidine (1)

First Public Date

2014 (1)

Study type

Transcription profiling by array (7)
ChIP-seq (2)
RNA-seq of coding RNA (2)
ChIP-chip by tiling array (1)
Other (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2021 (190)
2024 (189)
2022 (188)
2025 (176)
2023 (168)
2020 (138)
2018 (114)
2019 (112)
2015 (99)
2016 (85)
2017 (78)
2012 (58)
2014 (57)
2013 (55)
2011 (46)
2010 (28)
2009 (26)
2026 (26)
2008 (10)
2005 (6)
2006 (4)
2004 (4)
1999 (2)
2007 (1)

Lab affiliation

Bioplatforms Australia (7)
The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institutes of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China (2)
1Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA. Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA (1)
BioMedizinisches Centrum Walter-Brendel-Zentrum für Experimentelle Medizin Ludwig-Maximilians-Universität München (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht (1)
Bioplatforms Australia (project manager) (1)
Cancer Stem Cell and Translation Medicine Lab, Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China (1)
Department of Chemical Physiology and Biochemistry Oregon Health and Science University Portland, OR 97239 USA (1)
Department of Medicine, Weill Cornell Medicine, New York, NY, USA (1)
Department of Molecular Systems Biology, Microbiome biology Group, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany (1)
Department of Pharmacology and Toxicology University of Texas Medical Branch Galveston, TX 77555 USA (1)
Department of Radiology Canary Center at Stanford for Cancer Early Detection Stanford School of Medicine Stanford University (1)
Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA Department of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
Dr. Jörn Dengjel Prof. for Biochemistry and Cell Biology Department of Biology, University of Fribourg Chemin du Musée 10, 1700 Fribourg, Switzerland, T +41 26 300 8631, E joern.dengjel@unifr.ch, F +41 26 300 9741 (1)
Facility - Proteomics & Metabolomics (1)
MCTP, Rogel cancer center, Ann Arbor, Michigan, 48109 (1)
MCTP,Rogel cancer center, Ann Arbor, Michigan, 48109 (1)
Mayo Clinic (1)
School of Life and Environmental Sciences, Charles Perkins Centre, The University of Sydney (1)
ShanghaiTech university (1)
Sophie Paczesny, MD, PhD Professor of Pediatrics and Immunology Indiana University School of Medicine Wells Center for Pediatric Research Riley Hospital for Children, Melvin and Bren Simon Cancer Center, 1044 W. Walnut Street, Room R4-425 Indianapolis, IN, 46202 (1)
Toronto General Hospital Research Institute, UniversityHealth Network, Toronto, Canada Department of Medicine, Division of Nephrology, University Health Network, Toronto, Canada (1)

Tags

xref:PubMed:16478798 (1)
xref:PubMed:25313409 (1)

Previous page
1 / 199
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 199
Next page

Sort by:

Relevance

Page size

Lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal

Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao W, Lalonde J, Nakamura H, Konopaske G, Sidor M, Pernia C, Yamashita N, Wada M, Inoue Y, Nakamura F, Sheridan SD, Logan R, Brandel M, Wu D, Hunsberger J, Dorsett L, Duerr C, Basa RCB, McCarthy MJ, Udeshi N, Mertins P, Carr SA, Rouleau G, ...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2017-04-21 | MSV000080975 | MassIVE

FGF21 induced by carbon monoxide mediates metabolic homeostasis via the PERK/ATF4 pathway.

Not available

S-EPMC5901375 | biostudies-literature

Comparative profiling in 13 muscle disease groups

Summary: Genetic disorders of muscle cause muscular dystrophy, and are some of the most common inborn errors of metabolism. Muscle also rapidly remodels in response to training and innervation. Muscle weakness and wasting is important in such conditions as aging, critical care medicine, space flight...

ORGANISM(S): Homo sapiens

2005-10-14 | GSE3307 | GEO

Comparative profiling in 13 muscle disease groups

ORGANISM(S): Homo sapiens

2005-10-14 | E-GEOD-3307 | biostudies-arrayexpress

Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice.

Not available

S-EPMC6355067 | biostudies-literature

Non-targeted multimodal metabolomics and lipidomics data from ovine rumen fluid fractions

From an animal production and health perspective, our understanding of the metabolites in ruminant biofluids, particularly rumen fluid across different host species is poorly understood. Metabolomics is a powerful and sensitive approach for investigating low molecular weight metabolite profiles p...

2021-08-23 | MTBLS1717 | MetaboLights

Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression.

Not available

S-EPMC6570881 | biostudies-literature

National Estimates of Incremental Work Absenteeism Costs Associated With Adult Children of Parents With Alzheimer's Disease and Related Dementias.

Not available

S-EPMC11227392 | biostudies-literature

Schistosoma japonicum Cystatin Alleviates Sepsis Through Activating Regulatory Macrophages.

Not available

S-EPMC7943722 | biostudies-literature

Modified Sijunzi granule decreases post-weaning diarrhea in Rex rabbits via promoting intestinal development.

Not available